Loading clinical trials...
Loading clinical trials...
Cocaine-use disorders continue to be a significant public health concern, yet no effective medications have been identified. The goal of this study is to establish a research platform for the development of medications for treatment of cocaine abuse and dependence. This study will incorporate self-administration procedures and a non-drug alternative reinforcer, which is hypothesized to reduce the reinforcing effects of cocaine.
Age
21 - 45 years
Sex
ALL
Healthy Volunteers
No
Laboratory of Human Behavioral Pharmacology
Lexington, Kentucky, United States
Start Date
January 1, 2014
Primary Completion Date
June 1, 2015
Completion Date
June 1, 2015
Last Updated
May 17, 2019
9
ACTUAL participants
Cocaine
DRUG
Placebo
DRUG
Lead Sponsor
Joshua A. Lile, Ph.D.
NCT02455479
NCT06125054
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06189690